Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2023-06-30 00:00:00 ET · period of report 2023-06-28 · accession 0001439222-23-000109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-30 | 2023-06-30 | AGIO | Burns James William | CLO | S - Sale+OE | $28.36 | -1,707 | 30.3K | -5% | -$48.4K |
| D | 2023-06-30 | 2023-06-28 | AGIO | Burns James William | CLO | M - OptEx | $0.00 | +5,750 | 32.0K | +22% | $0 |
| D | 2023-06-30 | 2023-06-28 | AGIO | Burns James William | CLO | M - OptEx | $0.00 | -5,750 | 5,750 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-06-30 | S | D | 1,707 | $28.36 | 30,285 | D | — | — | |
| 2 | Common | Common stock | 2023-06-28 | M | A | 5,750 | $0.00 | 31,992 | D | — | — | |
| 3 | Derivative | Performance share units | 2023-06-28 | M | D | 5,750 | $0.00 | 5,750 | D | — · — to — | 5,750 Common stock | (F2) Each performance share unit represents a contingent right to receive one share of the issuer's common stock. (F3) The PSUs vest as to 50% of the underlying shares upon the achievement of a specified clinical milestone and as to 50% of the underlying shares upon the achievement of a specified research milestone. The performance criteria for the specified clinical milestone was determined to have been met on June 28, 2023, resulting in the vesting of the PSUs as to 50% of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. |